Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Physicians > Inman, Brant A.
Jumbo Large Regular Text:
Print
Physicians

Brant A. Inman, MD, MSc

Related Content

Locations

  • Duke Cancer Center

Services

  • Prostate Cancer
  • Urologic Cancers
  • Urologic Oncology

Health Library

  • Robots in the OR

Share

Brant A. Inman, MD, MSc

Department / Division
Surgery / Urology

Address
DUMC 2812
Durham, NC 27710

Appointment Telephone
919-668-8108

Office Telephone
919-681-8760

Fax Telephone
919-668-7093

Training
  • MD, University of Alberta (Canada), 2000

Residency
  • Urology, Laval University (Canada), 2005

Fellowship
  • Urologic Oncology, Mayo Clinic (Minnesota), 2008

Other Training
  • Fellow, Royal College of Surgeons of Canada, 2005
  • MSc, Mayo Clinic (Minnesota), 2011

Clinical Interests
Bladder cancer (including bladder-sparing options, robotic cystectomy, neobladders, hyperthermia); penile cancer (including penis-sparing options and inguinal lymphadenectomy); kidney cancer (including minimally invasive surgery, partial nephrectomy and vena caval thrombectomy); testicular cancer; urachal cancer; cancers of the ureter and renal pelvis; advanced genitourinary cancer surgery (including masses invading multiple organs and treatment-refractory tumors)

Research Interests
Clinical research interests:
Clinical trials of novel diagnostic tests and therapies for genitourinary malignancies, with a strong focus on bladder cancer.

Basic science research interests:
Immune therapies for cancer, molecular biology of bladder cancer, novel therapies--including hyperthermia--for bladder cancer.

Industry Relationships and Collaborations (What's this?)

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

  • GlaxoSmithKline

Representative Publications
Ashley, RA; Inman, BA; Routh, JC; Mynderse, LA; Gettman, MT; Blute, ML. Reassessing the diagnostic yield of saturation biopsy of the prostate. European Urology. 2008;53:976-981. (2008) Abstract

Inman, BA; Davies, JD; Rangel, LJ; Bergstralh, EJ; Kwon, ED; Blute, ML; Karnes, RJ; Leibovich, BC. Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL. Cancer. 2008;113:1544-1551. (2008) Abstract

Inman, BA; Frigola, X; Harris, KJ; Kuntz, SM; Lohse, CM; Leibovich, BC; Kwon, ED. Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma. Journal of Immunology. 2008;180:3578-3584. (2008) Abstract

Inman, BA; Myers, RP. Is the location of a positive surgical margin after radical prostatectomy important for prognosis?. Nature Reviews: Urology. 2008;5:476-477. (2008) Abstract

Magera, JS; Inman, BA; Slezak, JM; Bagniewski, SM; Sebo, TJ; Myers, RP. Increased optical magnification from 2.5x to 4.3x with technical modification lowers the positive margin rate in open radical retropubic prostatectomy. Journal of Urology. 2008;179:130-135. (2008) Abstract

Roth, TJ; Vandersteen, DR; Hollatz, P; Inman, BA; Reinberg, YE. Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children. Journal of Urology. 2008;180:306-311. (2008) Abstract

Routh, JC; Inman, BA; Ashley, RA; Vandersteen, DR; Reinberg, Y; Wolpert, JJ; Kramer, SA; Husmann, DA. Unilateral vesicoureteral reflux: does endoscopic injection based on the cystoscopic appearance of the ureteral orifice decrease the incidence of de-novo contralateral reflux?. Journal of Pediatric Urology. 2008;4:260-264. (2008) Abstract

Routh, JC; Inman, BA; Reinberg, Y. Re: Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children. W. H. Cerwinka, H. C. Scherz and A. J. Kirsch. J Urol 2007; 178: 1469-1473. Journal of Urology. 2008;179:1205. (2008) Abstract

Routh, JC; Kramer, SA; Inman, BA; Ashley, RA; Wolpert, JJ; Vandersteen, DR; Husmann, DA; Reinberg, Y. Utility of dextranomer/hyaluronic acid injection in setting of bladder and ureteral anomalies. Urology. 2008;71:435-438. (2008) Abstract

Sengupta, S; Blute, ML; Bagniewski, SM; Inman, B; Leibovich, BC; Slezak, JM; Myers, RP; Zincke, H. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. BJU International. 2008;101:170-174. (2008) Abstract

Siddiqui, SA; Boorjian, SA; Inman, B; Bagniewski, S; Bergstralh, EJ; Blute, ML. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. Journal of Urology. 2008;179:1830-1837. (2008) Abstract

Ashley, RA; Inman, BA; Routh, JC; Krambeck, AE; Siddiqui, SA; Mynderse, LA; Gettman, MT; Blute, ML. Preventing pain during office biopsy of the prostate: a single center, prospective, double-blind, 3-arm, parallel group, randomized clinical trial. Cancer. 2007;110:1708-1714. (2007) Abstract

Ashley, RA; Inman, BA; Routh, JC; Rohlinger, AL; Husmann, DA; Kramer, SA. Urachal anomalies: a longitudinal study of urachal remnants in children and adults. Journal of Urology. 2007;178:1615-1618. (2007) Abstract

Boorjian, SA; Frank, I; Inman, B; Lohse, CM; Cheville, JC; Leibovich, BC; Blute, ML. The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. Urology. 2007;70:1064-1068. (2007) Abstract

Inman, BA; Frigola, X; Dong, H; Kwon, ED. Costimulation, coinhibition and cancer. Current Cancer Drug Targets. 2007;7:15-30. (2007) Abstract

Inman, BA; Sebo, TJ; Frigola, X; Dong, H; Bergstralh, EJ; Frank, I; Fradet, Y; Lacombe, L; Kwon, ED. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer. 2007;109:1499-1505. (2007) Abstract

Magera, JS; Inman, BA; Elliott, DS. Does preoperative topical antimicrobial scrub reduce positive surgical site culture rates in men undergoing artificial urinary sphincter placement?. Journal of Urology. 2007;178:1328-1332. (2007) Abstract

Roth, TJ; Sheinin, Y; Lohse, CM; Kuntz, SM; Frigola, X; Inman, BA; Krambeck, AE; McKenney, ME; Karnes, RJ; Blute, ML; Cheville, JC; Sebo, TJ; Kwon, ED. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Research. 2007;67:7893-7900. (2007) Abstract

Routh, JC; Reinberg, Y; Ashley, RA; Inman, BA; Wolpert, JJ; Vandersteen, DR; Husmann, DA; Kramer, SA. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection. Journal of Urology. 2007;178:1702-1705. (2007) Abstract

Webster, WS; Thompson, RH; Harris, KJ; Frigola, X; Kuntz, S; Inman, BA; Dong, H. Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine. Journal of Immunology. 2007;179:2860-2869. (2007) Abstract

Ashley, RA; Inman, BA; Sebo, TJ; Leibovich, BC; Blute, ML; Kwon, ED; Zincke, H. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer. 2006;107:712-720. (2006) Abstract

Inman, BA. Re: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial. Journal of Urology. 2006;175:1960. (2006) Abstract

Inman, BA; DiMarco, DS; Slezak, JM; Sebo, TJ; Kwon, ED; Leibovich, BC; Blute, ML; Zincke, H. Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy. Urology. 2006;68:604-608. (2006) Abstract

Inman, BA; Myers, RP. Re: Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J. S. Jones, A. Patel, L. Schoenfield, J. C. Rabets, C. D. Zippe and C. Magi-Galluzzi. J Urol, 175: 485-488, 2006. Journal of Urology. 2006;176:1252-1253. (2006) Abstract

Siddiqui, SA; Inman, BA; Sengupta, S; Slezak, JM; Bergstralh, EJ; Leibovich, BC; Zincke, H; Blute, ML. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Cancer. 2006;107:521-529. (2006) Abstract

Inman, BA; Harel, F; Audet, JF; Meyer, F; Douville, P; Fradet, Y; Lacombe, L. Insulin-like growth factor binding protein 2: an androgen-dependent predictor of prostate cancer survival. European Urology. 2005;47:695-702. (2005) Abstract

Inman, BA; Harel, F; Tiguert, R; Lacombe, L; Fradet, Y. Routine nasogastric tubes are not required following cystectomy with urinary diversion: a comparative analysis of 430 patients. Journal of Urology. 2003;170:1888-1891. (2003) Abstract

Inman, B; Halloran, B; Melk, A; Ramassar, V; Halloran, PF. Microchimerism in sensitized renal patients. Transplantation. 1999;67:1381-1383. (1999) Abstract

Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En EspaƱol | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Oct. 28, 2010
Published: Sept. 25, 2008
URL: http://www.dukehealth.org/physicians/brant_a_inman